SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

30 Sep 2022 07:00

RNS Number : 2444B
Numis Corporation PLC
30 September 2022
 

30 September 2022

Numis Corporation Plc (Numis)

Trading update

 

Numis (LON: NUM), the international investment bank, today issues a trading update in respect of the year ending 30 September 2022.

Key highlights:

· Revenue for the full year is expected to be approximately £144m, representing a decline of around 33% compared to a record period in FY21

· Record advisory revenue performance reflects continued progress in diversifying the business; strong pipeline and the outlook for M&A revenues remains positive

· Uncertain global economic environment has caused capital markets activity to remain subdued throughout H2

· Following regulatory approval, Dublin office is operational and trading with a growing list of EU-based institutional clients

 

Strong M&A revenues partially offsets weaker capital markets performance

Investment banking revenues are expected to be approximately 39% lower than the prior year due to weaker capital markets revenues compared to a particularly strong 2021. Both public and private markets experienced a significant reduction in deal volumes year-on-year as investor sentiment continued to be impacted by the uncertain macro-economic outlook. However, this was partially offset by a record advisory revenue performance for the second successive year reflecting further progress against our long term objective to diversify our investment banking business.

 

Challenging market backdrop for equities clients

Equities revenues will be above £50m, but approximately 17% lower than the prior record year, with H2 revenue performance weaker than H1 due to lower institutional income. Our performance for the year reflects a challenging period for our institutional clients who have generally suffered outflows across UK focused funds resulting in lower trading volumes, particularly in mid-cap stocks. Following regulatory approval, our Dublin office is now operational and trading with a growing list of EU-based clients in line with our international strategy.

 

Outlook

Our near term M&A pipeline is strong and we are currently acting as financial adviser on nine announced public bids with an average transaction value of more than £1.5bn. However, the macro-economic and geo-political environment remain highly volatile and predicting the timing of any improvement in capital markets activity is very difficult. We remain committed to executing our long term corporate strategy to diversify our revenue streams which, combined with a strong balance sheet, supports our ability to deliver consistent returns to shareholders across the cycle. Consistent with previous periods of market volatility we will continue to invest in talent pursuant to our strategy.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

-ENDS -

 

Contacts:

 

Numis:

Noreen Biddle Shah, Head of Communications 020 7260 1441

 

FTI Consulting LLP:

Edward Bridges 07768 216607

Daisy Hall 07807 298568

Grant Thornton UK LLP (Nominated Adviser): Philip Secrett 020 7728 2578Harrison Clarke 020 7184 4384

 

 

About Numis

Numis (LON: NUM) is an international investment bank that partners with the most ambitious companies and investors, offering strategic advice, unique insights and connectivity to the capital markets.Already a leader in the UK market, Numis is the adviser of choice for listed companies, including one fifth of the FTSE 350 index and has acted on the most UK IPOs over the past decade.Since 2016, Numis has diversified its strategy to grow its UK M&A franchise, expand internationally and develop its private markets business.Founded in 1989, Numis is listed on London's AIM and has offices in London, New York, and Dublin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKVNRUWUKUAR
Date   Source Headline
1st Jun 20204:07 pmRNSTransaction in Own Shares and Total Voting Rights
29th May 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20209:55 amRNSTransaction in Own Shares and Total Voting Rights
18th May 20201:48 pmRNSTransaction in Own Shares and Total Voting Rights
12th May 20207:00 amRNSHalf-year Report
6th May 20207:00 amRNSRelease date of half year results
27th Apr 20204:42 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 202011:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Mar 20207:00 amRNSTrading Update
23rd Mar 20205:23 pmRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20204:54 pmRNSTransaction in Own Shares and Total Voting Rights
16th Mar 20202:15 pmRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20209:14 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20202:12 pmRNSTransaction in Own Shares and Total Voting Rights
5th Mar 20205:40 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Mar 20205:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Feb 202011:21 amRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20205:15 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20201:05 pmRNSResult of AGM
4th Feb 20207:00 amRNSAGM Trading Update
3rd Feb 20202:09 pmRNSTR-1: Notification of major holdings
3rd Feb 202012:44 pmRNSTransaction in Own Shares and Total Voting Rights
31st Jan 202010:16 amRNSTR-1: Notification of major holdings
30th Jan 20204:36 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jan 20203:07 pmRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20204:25 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 202010:16 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 202011:00 amRNSDirector Dealing
20th Jan 20205:46 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 20204:16 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20202:03 pmRNSTR-1: Notification of major holdings
2nd Jan 20207:00 amRNSAnnual Report and Annual General Meeting Notice
30th Dec 201911:00 amRNSTR-1: Notification of major holdings
19th Dec 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Dec 20192:41 pmRNSDirectors' Dealing
13th Dec 20192:14 pmRNSTR-1: Notification of major holdings
10th Dec 20196:00 pmRNSTransfer of Shares from Treasury to EBT and TVR
5th Dec 20194:29 pmRNSDirector dealing
4th Dec 20197:00 amRNSPreliminary Results for the year ended 30 Sep 2019
2nd Dec 20195:27 pmRNSTransaction in Own Shares and Total Voting Rights
29th Nov 201910:08 amRNSTransaction in Own Shares and Total Voting Rights
25th Nov 20193:39 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 201911:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Nov 201911:00 amRNSTR-1: Notification of major holdings
15th Nov 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Nov 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Oct 20193:35 pmRNSTransaction in Own Shares and Total Voting Rights
25th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Oct 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.